SOHO Global Health is one of Indonesia's leading pharmaceutical and healthcare corporations in manufacturing, distributing, and providing quality health products and services with its current reputable brands such as Diapet, Laxing, Lelap, Fitkom and Curcuma Plus.
We focus on manufacturing - including under-licensed - herbal products (immunomodulator, antioxidant, anti diarrhea, anti laxantia) and synthetic products (antibiotic, cephalosporin, injection preparation, antiemetic, analgesic, musculoskeletal, vitamin, obgyn, gastro, neuro, and rheumatology products)
SOHO Global Health consists of 2 synergy business units: Healthcare Business Unit and Commercial Business Unit thus are supported by Support Functions Unit consist of Finance, Human Capital Development & Public Affair, Business Technology, Legal Compliance, Supply & Operations, Office of Strategy Management and Corporate Secretary.
We distribute pharmaceutical and healthcare products of our companies, and other pharmaceutical and consumer goods manufacturers under the flag of PT. Parit Padang Global, supported by our branches covering 90% of major cities in Indonesia.
Our global presence in emerging markets: Malaysia, Myanmar, Nigeria, Lebanon, Mongolia, Vietnam, Suriname, Brunei, Mauritius, Sri Lanka, Pakistan.
In 2005 we started adopting Balanced Scorecard framework to translate strategy into operational objectives that drive both behavior and performance. Since then, have been investing heavily in Product Development, Human Capital and Information Capital in order to improve and upgrade these aspects across the organization since 2005 in order to reach VISION 2015: New Horizon Strategy to create our future together.